Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02947685
Title Randomized, Open Label, Clinical Study of the Targeted Therapy, Palbociclib, to Treat Metastatic Breast Cancer (PATINA)
Recruitment Recruiting
Gender both
Phase Phase III
Variant Requirements Yes
Sponsors Alliance Foundation Trials, LLC.
Indications

Her2-receptor positive breast cancer

Therapies

Fulvestrant

Pertuzumab

Letrozole

Anastrozole

Exemestane

Palbociclib

Trastuzumab

Age Groups: adult | senior
Covered Countries USA | NZL | ITA | FRA | ESP | DEU | AUS

Additional content available in CKB BOOST